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Deletion of SHIP or SHP-1 Reveals
Two Distinct Pathways
for Inhibitory Signaling
Masao Ono,* Hidetaka Okada,² Silvia Bolland,* anaphylactic responses (Takai et al., 1996). Similar hy-
perresponsive phenotypes have been observed in lym-Shigeru Yanagi,³ Tomohiro Kurosaki,²
phocytes following the disruption of CD22 (O'Keefe etand Jeffrey V. Ravetch*
al., 1996; Otipoby et al., 1996; Sato et al., 1996; Nitschke*Laboratory of Molecular Genetics and
et al., 1997), CTLA4 (Tivol et al., 1995), and CD5 (BikahImmunology
et al., 1996), suggesting that the primary role of theseThe Rockefeller University
coreceptors is to mediate the inhibition of activationNew York, New York 10021
responses initiated by the ITAM family of receptors.²Department of Molecular Genetics
Several features have emerged that are common toInstitute for Liver Research
these inhibitory receptors. A consensus inhibitory motifKansai Medical University
(ITIM) first identified in FcgRIIB, I/LxYxxL (Muta et al.,Moriguchi 570
1994), has been recognized in the cytoplasmic domainsJapan
of this growing family of inhibitory molecules (Castells³Department of Biochemistry
et al., 1994; Hayami et al., 1997). Inhibitory activity is onlyKobe University School of Medicine
seen upon coligation to an ITAM-containing receptorKobe 650
(Daeron et al., 1995a), a class that includes BCR, TCR,Japan
and FcRs for IgG and IgE. Phosphorylation of the tyro-
sine in the ITIM by an ITAM-associated tyrosine kinase
is critical to its inhibitory mechanism (Muta et al., 1994;
Summary Binstadt et al., 1996). In the case of FcgRIIB, coligation
to the BCR or mast cell FceRI or FcgRIII results primarily
Two signaling molecules have been implicated in the in the recruitment of the SH2-containing inositol phos-
modulation of immune receptor activation by inhibi- phatase SHIP (Ono et al., 1996), although in vitro the
tory coreceptors: an inositol polyphosphate 59-phos- tyrosine phosphatases SHP-1 and -2 have also been
phatase, SHIP, and a tyrosine phosphatase, SHP-1. To reported to be associated with this receptor (D'Am-
address the necessity, interaction, or redundancy of brosio et al.,1995). Similarly, phosphorylation of the ITIM
these signaling molecules, we have generated SHP-1- in KIR, CD22, and gp49B1 results in the recruitment of
or SHIP-deficient B cell lines and determined their abil- SHP-1 (Burshtyn et al., 1996; Campbell et al., 1996; Fry
ity to mediate inhibitory signaling. Two distinct classes et al., 1996; Law et al., 1996; Olcese et al., 1996), while
of inhibitory responses are defined, mediated by the SHP-2 has been found to be associated with CTLA4
(Marengere et al., 1996).selective recruitment of SHP-1 or SHIP. The FcgRIIB
However, despite these similarities in sequence re-class of inhibitory signaling is dependent on SHIP and
quirements and potential signaling pathways, the inhibi-not SHP-1; conversely, the KIR class requires SHP-
tory responses generated by these receptors are not1 and not SHIP. The consequence of this selective
identical. For example, while calcium signaling is per-recruitment by inhibitory receptor engagement is seen
turbed in all of the inhibitory responses, it is primarilyin BCR-triggered apoptosis. SHP-1-mediated inhibi-
the result of a block in calcium influx for the case oftory signaling blocks apoptosis, while SHIP recruit-
FcgRIIB, with minimal effects seen on release of calciumment attenuates a proapoptotic signal initiated by
from intracellular stores (Choquet et al., 1993; Muta etFcgRIIB.
al., 1994). In contrast, CD22 or KIR inhibitory responses
block the release of calcium from intracellular stores
Introduction (O'Keefe et al., 1996; Blery et al., 1997). In addition,
differences have been observed in the phosphorylation
Termination of activation signals is a critical component state of intracellular substrates, such as PLCg1 and
of the immune response; perturbation of these inhibitory CD19. Engagement of KIR or FcgRIIB results in changes
pathways results in profound immune defects charac- in distinct subsets of tyrosine kinase substrates; KIR
terized by decreased activation thresholds and hyper- engagement results in the dephosphorylation of a sub-
responsive phenotypes, culminating in the sequelae of set of proteins like protein tyrosine kinase (PTK), ZAP-
autoimmunity and inflammation. Multiple receptorshave 70, PLCg, or its adapter pp36 (Binstadt et al., 1996;
been identified with the capacity to abrogate activation Valiante et al., 1996), while FcgRIIB engagement leads
responses. Thus, B cell activation and mast cell degran- to detectable changes in a different subset of proteins,
ulation are inhibited by immune complexes through their including dephosphorylation of CD19 (Kiener et al.,
coligation to FcgRIIB (Phillips and Parker, 1983, 1984; 1997). These differences suggest that FcgRIIB utilizes
Amigorena et al., 1992; Muta et al., 1994; Daeron et al., a different signaling mechanism than KIR and CD22.
1995b), while NK and T cell activation is terminated by Indeed, the recruitment of either an inositol polyphos-
engagement of the killer cell inhibitory receptor (KIR) phate 59-phosphatase (SHIP) or a tyrosine phosphatase
class of molecules with MHC class I (Moretta et al., is likely to trigger distinct cellular pathways (reviewed by
1993; Mingari et al., 1995; Phillips et al., 1995; Vitale et Scharenberg and Kinet, 1996), culminating in inhibitory
al., 1995; D'Andrea et al., 1996). Targeted disruption of responses that are phenotypically quite different. We
now report the consequences of disruption of either ofFcgRIIB results in mice with enhanced antibody and
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consistent with previous reports indicating that FcgRIIB
engagement inhibits calcium influx (Choquetet al., 1993;
Muta et al., 1994), while KIR acts on the release of intra-
cellular calcium (Blery et al., 1997). However, in contrast
to previous reports (D'Ambrosio et al., 1995), SHIP and
SHP-1 are selectively recruited to the cytoplasmic do-
mainsof these two inhibitory receptors, as seen inFigure
2C. Immunoprecipitation of the coligated BCR and inhib-
itory receptors, followed by Western blotting with either
SHP-1 or SHIP, clearly demonstrates that SHIP is only
detected in association with the FcgRIIB cytoplasmic
domain, while SHP-1 is found associated only with the
KIR cytoplasmic domain.
The Catalytic Activities of SHIP or SHP-1Figure 1. Expression Constructs Used in This Study
Are Sufficient for Inhibitory SignalingA schematic representation of the deduced proteins is shown. The
To determine if recruitment of SHIP and SHP-1 to theextracellular and transmembrane domains of each protein are de-
rived from the mouse FcgRIIB sequence (white box). The shaded cytoplasmic domains of FcgRIIB and KIR, respectively,
box indicates the portion of the cytoplasmic domain derived from was sufficient to account for the differential inhibitory
KIR, SHIP, or SHP-1. The underlined amino acid residues indicate effects observed for calcium mobilization, chimeras ex-
those mutated resulting in inactivation of 5-Pase activity of SHIP.
pressing the catalytic domains of SHIP or SHP-1 in placeThe amino acid sequence corresponding to theconsensus inhibitory
of the cytoplasmic domain of FcgRIIB were expressedmotif is indicated by the black box and bold sequence.
in DT40 wild-type cells. These chimeras retain theircata-
lytic activity as measured by Ins(1,3,4,5)P4 hydrolysis for
SHIP constructs or tyrosine phosphatase activity in thethese signaling molecules on the inhibitory response
case of SHP-1 fusions (data not shown). Coligation of theand demonstrate a selective role of these inhibitory sig-
BCR to these molecules resulted in calcium inhibitionnaling molecules in receptor-triggered apoptosis.
profiles (Figure 3A) or NF-AT-induced transcription (Fig-
ure 3B) identical to the intact receptor domains (FigureResults
2). However, a SHIP chimera with an inactive inositol
phosphate domain was unable to mediate the inhibitorySHIP and SHP-1 Are Selectively Recruited
effect (Figures 3A and 3B). Recruitment of the catalyticby FcgRIIB and KIR, Respectively
activities of these phosphatases to the membrane isA genetic strategy was taken to determine if SHIP and
sufficient to inhibit calcium accumulation and NF-ATSHP-1 were autonomous, interacting, or redundant in
stimulated transcription, indicating that the role of theinhibitory signaling in B lymphocytes. FcgRIIB and KIR
cytoplasmic domain of FcgRIIB and KIR is to recruit thewere used as prototypes of inhibitory receptors with
respective catalytic domains of the signaling moleculespotentially different signaling requirements. A series of
SHIP or SHP-1 to the activated BCR complex.chimeric molecules were constructed in which the intra-
cytoplasmic sequences containing the inhibitory motifs
were exchanged between FcgRIIB and KIR or replaced SHIP Is Necessary for FcgRIIB Inhibition While
SHP-1 Is Necessary for KIR Inhibitionwith the catalytic domains of SHIP, SHP-1, or SHIPD5Pase,
an inositol phosphatase-negative mutant of SHIP, as While recruitment of SHIP or SHP-1 was sufficient to
account for the inhibitory effect on intracellular free cal-shown in Figure 1. These molecules were transfected
into mouse (A20, IIA1.6) and chicken (DT40, DT40DSHIP, cium accumulation and NF-AT-stimulated transcription
upon BCR activation, the experiments presented in Fig-DT40DSHP-1) B cell lines to obtain stable transformants.
Murine A20 lines expressing comparable levels of ures 2 and 3 do not address the necessity of expressing
these molecules for a particular inhibitory receptor.transfected receptors were stimulated by B cell immu-
noglobulin receptor (BCR) cross-linking alone (thin trac- Thus, SHP-1 and SHIP may function as complementary
or redundant signaling molecules. To explore this possi-ing) or coligation of BCR and the inhibitory receptor
(thick tracing) (Figure 2A). Coligation of an inhibitory bility, B-cell lines lacking either SHP-1 or SHIP mole-
cules were constructed using the chicken DT40 cell line.receptor to the BCR results in an inhibition of intracellu-
lar free calcium (Figure 2A) and the nuclear factor of The molecules shown in Figure 1 were transfected into
DT40 wild-type and mutant cells and compared for theiractivated T cells (NF-AT)-stimulated transcription of a
reporter gene (Figure 2B),an activity that in turn depends ability to mediate inhibitory signaling responses. As
shown in Figures 4A and 4B, FcgRIIB-mediated inhibi-on the calcium-sensitive translocation of NF-AT cyto-
solic component to the nucleus (Timmerman et al., tion of calcium accumulation was unaffected in SHP-
1-deficient DT40 cells, consistent with our previous re-1996). FcgRIIB-mediated inhibition is sensitive to the
presence of EGTA in the medium, while KIR inhibition sults obtained in mast cells deficient in SHP-1 obtained
from me/me mice (Ono et al., 1996), but was abrogatedis resistant to calcium chelation by EGTA. BCR-induced
calcium mobilization is due to its release from intracellu- inSHIP-deficient cells. Conversely,KIR-mediated inhibi-
tion was substantially reduced in SHP-1-deficient cellslar stores and influx from the environment. Since EGTA
treatment blocks only calcium influx, these results are and unperturbed in SHIP-deficient cells. A similar result
Inhibitory Signaling in B cells
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Figure 2. Inhibitory Response Mediated by
FcgRIIB or KIR Inhibitory Motif in the Murine
A20 B Cell Line
(A)Intracellular calcium mobilization triggered
with F(ab9)2 anti-mouse IgG, resulting in BCR
cross-linking (thin tracing), or with intact anti-
mouse IgG, resulting in coligation of BCR to
inhibitory receptor (thick tracing). Arrows in-
dicate the time point for adding the antibody.
Calcium release from intracellular calcium
store was measured in the presence of 1 mM
EGTA (1EGTA). Histograms indicate the ex-
pression level of inhibitory receptor by 2.4G2
staining. FcgRIIB negative staining is indi-
cated by the dotted line.
(B) NF-AT activity measured with a luciferase
reporter construct driven by an NF-AT sensi-
tive promotor. NF-AT activity was normalized
to that of BCR stimulation alone.
(C) SHIP or SHP-1 association with inhibitory
receptorupon itscoligation to BCR. Inhibitory
receptors in cell lysates were immunoprecipi-
tated with 2.4G2-conjugated sepharose and
analyzed by Western blotting using anti-SHP-1,
anti-SHIP, anti-phosphotyrosine (a pTyr),
and anti-FcgRIIB cytoplasmic domain (aFcg
RIIBcyt). Associated proteins are noted; non-
specific signals corresponding to the heavy
chain of anti-mouse IgG and 2.4G2 are appar-
ent in the anti-SHP-1 blot.
was seen using NF-AT activation as a measure of the loss of SHIP recruitment to FcgRIIB or a nonspecific
consequence of perturbing otherSHIP-dependent path-inhibitory response (Figure 4C). These results formally
demonstrate that the two inhibitory receptors mediate ways in the cells. Coligation of an FcgRIIB mutant (Y .
F) that is unable to recruit SHIP lowered the thresholdtheir responses through independent signaling path-
ways, initiated by the recruitment of either SHIP or for proliferative arrest by an order of magnitude (Figure
5B). This enhancement of BCR-triggered growth arrestSHP-1.
by FcgRIIB was further characterized by determining the
incidence of apoptotic cells induced by BCR-FcgRIIBBCR-Induced Apoptosis Is Differentially Affected
by Recruitment of SHIP or SHP-1 cross-linking in wild-type and SHIP-deficient cells.
When subthreshold conditions are used for BCR-in-Since SHIP and SHP-1 have different substrates, are
coupled to different signaling pathways, and have dis- duced apoptosis (1 mg/ml), as seen in Figure 6, loss of
SHIP recruitment increases the incidence of apoptotictinct effects on calcium accumulation, we reasoned that
an integrated cellular phenotype, like apoptosis, might cells by a factor of five. This proapoptotic effect seen
upon cross-linking this mutant receptor indicates thatbe differentially influenced by these distinct inhibitory
pathways. DT40 cells undergo receptor-triggered apo- FcgRIIB delivers a potent proapoptotic signal to these
cells, which is attenuated by recruitment of SHIP.ptosis in response to BCR cross-linking (Takata et al.,
1995). Coligation of BCR to FcgRIIB in wild-type DT40
cells does not affect growth arrest as measured by thy- Discussion
midine incorporation (Figure 5A), while KIR engagement
inhibits the apoptosis triggered by BCR stimulation. In Stimulation of antigen receptors on lymphocytes can
result in either positive or negative signaling, resultingthe absence of SHP-1, KIR engagement has no effect
on BCR-triggered growth arrest. In contrast, engage- in activation responses leading to immunity or inhibitory
responses leading to tolerance (Goodnow et al., 1989;ment of FcgRIIB to BCR in SHIP-deficient cells results
in a dramatic enhancement of the apoptotic response Hartley et al., 1991; reviewed by Schwartz, 1989; Good-
now, 1992; Nossel, 1994). Modulating these receptorsof these cells. This enhancement lowers the threshold
for apoptosis, as shown in Figure 5A, and accelerates are a variety of coreceptors that serve to enhance or
attenuate the antigen receptor response. In the caseentry into apoptosis (data not shown). We further char-
acterized this proapoptotic response to determine if the of inhibitory receptors like FcgRIIB, CD22, or KIR, two
signaling pathways had been identified, although theenhancement is the result of a specific effect of the
Cell
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single SH2 domain-containing protein (Damen et al.,
1996; Kavanaugh et al., 1996; Lioubin et al., 1996). This
difference in the SH2 domains and SH2 sites between
SHP-1-KIR and SHIP-FcgRIIB may underlie the basis
for the selective recruitment of these phosphatases. In
addition, we have demonstrated that the inositol phos-
phatase catalytic domain is required for inhibition (Fig-
ure 3), thereby establishing the inositol polyphosphate
substrates IP4 and PIP3 as likely targets of this inhibitory
response. These results support the model proposed
earlier (Ono et al., 1996; reviewed by Ravetch, 1997) that
SHIP mediates its inhibitory effect by its translocation to
the cell surface, bringing it into proximity with substrates
that, either directly or indirectly, gate a calcium channel.
One unexpected finding reported in this study was
the identification of a potent proapoptotic activity asso-
ciated with FcgRIIB. This activity was only apparent
when SHIP recruitment was blocked, either by deletion
of SHIP from the cell or by mutation of the receptor
(Y . F), preventing it from associating with SHIP. This
enhancement is unlikely to result from increasing the
extent of BCR cross-linking, since the effect is specific
for FcgRIIB. Replacing FcgRIIB with a chimeric receptor
expressing the KIR cytoplasmic sequences in SHP-12/2
DT-40 cells does not affect apoptosis, yet the degree
Figure 3. Inhibitory Response Mediated by SHIP and SHP-1 Chime- of BCR cross-linking is similar. Furthermore, FcgRIIB
ric Receptors cross-linking alone is not able to induce an apoptotic
FcgRII-SHIPDSH2, FcgRII-SHP-1DSH2, and FcgRII-SHIPDSH2D5Pase mutant signal (data not shown), suggesting that this proapo-
(defect in inositol polyphosphate 5-phosphatase activity) chimeric ptotic activity is dependent on BCR activation. These
receptors were expressed in DT40 chicken B cells.
results indicate that SHIP recruitment blocks the pro-(A) Intracellular calcium mobilization triggered by anti-chicken IgM
apoptotic effect and suggest a mechanism for its action.plus F(ab9)2 anti-mouse IgM, resulting in BCR stimulation (thin trac-
If the proapoptotic factor isa calcium-dependent activa-ing), or anti-chicken IgM plus intact anti-mouse IgM, resulting in
coligation of the BCR to inhibitory receptor (thick tracing). Condi- tor, then by inhibiting calcium influx, SHIP recruitment
tions are the same as described in Figure 2A. would modulate the activity of the activator.
(B) NF-AT activity in response to coligation of BCR to chimeric A model for these opposing effects is proposed in
receptor, as described in Figure 2B.
Figure 7. BCR cross-linking by self antigen, for example,
can lead to an apoptotic response and result in negative
specificity and autonomy of these pathways and the selection. CD22 can inhibit this BCR-triggered apoptotic
consequences of their selective engagement were un- response by the recruitment of SHP-1 (Doody et al.,
known. In this study, we provide genetic evidence for 1995), thereby setting a threshold for antigen to induce
the independence of the tyrosine (SHP-1) and inositol apoptosis. Absence of this pathway would be predicted
phosphatase (SHIP) pathways and the consequence of to result in inappropriate deletion of B cells (Cyster and
engaging either on antigen receptor-triggered apo- Goodnow, 1995). Consistent with this prediction, dele-
ptosis. tion of CD22 results in B cellswith an enhanced capacity
The SH2-containing tyrosine phosphatase SHP-1 is for apoptosis in vitro and the elimination in vivo of the
both necessary and sufficient to mediate inhibitory sig- transitional B cell, a cell shown to be sensitive to nega-
naling by receptor containing the KIR class of ITIMs. tive selection (Nitschke et al., 1997). In contrast, the
These motifs preferentially associate with SHP-1; lossof coligation of BCR to FcgRIIB by immune complexes
SHP-1 inactivates this inhibitory receptor. This selective results in enhanced apoptosis, mediated by a undefined
association may be the result of the presence of two proapoptotic factor associated with the receptor, whose
SH2 domains in SHP-1 (Shen et al., 1991; Yi et al., 1992) activity can be attenuated by the recruitment of SHIP.
and two SH2 sites in the KIR inhibitory motif (Colonna The degree of attenuation will be determined by the
and Samaridis, 1995; Wagtmann et al., 1995). A similar presence of two opposing activities associated with
situation is likely to exist for CD22 and gp49B1, which FcgRIIB: an apoptosis-enhancing activity and SHIP. The
contain two SH2 sites (Stamenkovic and Seed, 1990; balance between these opposing activities could deter-
Castells et al., 1994). Consistent with this model, chime- mine if an immune complex enhances or attenuates an
ras constructed with theCD22 cytoplasmic domain were apoptotic signal. Developmental regulation of SHIP
inhibitory when cross-linked to the BCR in A20 or DT40 would be one mechanism for modulating an apoptotic
cells and required the presence of SHP-1 to mediate a signal and would predict that immature cells would be
maximal inhibitory response (data not shown). In con- low in SHIP, while mature, proliferative cells would have
trast, FcgRIIB preferentially associates with SHIP and higher levels of SHIP. In this regard, the finding that
cannot mediate an inhibitory response in the absence coengagement of FcgRIIB and BCR in splenic B cells
of this molecule. FcgRIIB contains a single SH2 site in delivers a weakly apoptotic signal (Ashman et al., 1996;
Yamashita et al., 1996) suggests that these mature cellsits inhibitory motif (Muta et al., 1994), and SHIP is a
Inhibitory Signaling in B cells
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Figure 4. Abrogation of FcgRIIB or KIR Inhib-
itory Response in SHIP-Deficient (SHIP2/2)
and SHP-1-Deficient Cell (SHP-12/2), Re-
spectively
DT40 and its derived lines were used in this
study.
(A) Intracellular calcium mobilization trig-
gered as in Figure 3.
(B) Cumulative intracelluar calcium mobiliza-
tion during 4 min after stimulation in each
cell type. Total calcium mobilization of the
coligation sample was normalized to that of
BCR stimulation alone. Three independent
experimentswere performed; standarderrors
are indicated.
(C) NF-AT activity in response to coligation
of BCR to inhibitory receptor.
were maintained in RPMI 1640 medium supplemented with 10%express higher levels of SHIP,damping the proapoptotic
FCS, 1% chicken serum (Sigma, Saint Louis, MO), 50 mM 2-mercap-signal of FcgRIIB. In addition, stimuli that modulate SHIP
toethanol, 2 mM L-glutamine, and antibiotics. FcgRIIB constructsexpression could determine whether an immune com-
including FcgRIIB (Y . F) were described previously (Muta et al.,
plex resulted in positive or negative selection. Such 1994). Mouse anti-chicken IgM MAb M4 (mouse IgM) and rabbit
stimuli could include CD40 or IL-4, factors known to anti-FcgRIIBcyt (previously termed as anti-mb1) were previously
described (Chen et al., 1982; Ono et al., 1996). Intact and F(ab9)2influence B cell fate. A mechanism such as that pro-
fragment of both rabbit anti-mouse IgM and rabbit anti-IgG (H 1 L)posed here could account for the postulated role of
(Zymed, San Francisco, CA), 2.4G2 (PharMingen, San Diego, CA),the immune complex in the germinal center during the
anti-human SHP-1, and anti-phosphotyrosine, 4G10 (Upstate Bio-secondary immune response and in the generation of
technology, Inc., Lake Placid, NY), were purchased. Anti-mouse
memory cells. SHIP serum was developed in rabbit immunized with GST fusion
SHIP and SHP-1 are both potent inhibitors of ITAM- protein consisting of SHIP proline-rich domain. The cDNA of mouse
FcgRIIB and human NK cell inhibitory receptor (KIR) were fused attriggered activation with specificity for particular core-
the carboxy-terminal residue of the transmembrane domain of eachceptors. Despite this common ability to abrogate the
protein by using PCR with the following junction primers: RII-KIRactivation response, the pathways to which these phos-
primer, 59-TGGTCTATCTCCATCGCTGGTGCTGCAACA-39 and KIR-phatases are coupled are not overlapping or redundant.
RII primer, 59-CCAGCGATGGAGATAGACCAAGGATACT-39. The
The consequence of this specificity is apparent for the cDNA of mouse FcgRIIB and mouse SHP-1 were fused at the amino-
apoptotic response, where the choice of coreceptors terminal residue of the inhibitory motif in FcgRIIB and in the domain
between the SH2 and tyrosine phosphatase regions of SHP-1 withwill either enhance or inhibit receptor-triggered cell
the following junction primers: RII-SHP-1 primer, 59-GGAAAACTGAdeath. These pathways, then, offer the B lymphocyte
GGGCTT(CT)TGGGA(AG)GAGTTTG-39 and SHP-1-RII primer, 59-the ability to discriminate between stimuli and modulate
TCCCA(AG)AAGCCCTCAGTTTTGGCAGCTTCT-39. Nucleotides in
the subsequent response. Whether a similar situation parentheses are mixtures of the two bases. For construction of the
exists in other cell types remains to be determined. chimeric cDNA of mouse FcgRIIB and mouse SHIP, a 3.1 kb cDNA
fragment was excised at BstEII restriction site in the sequence sepa-
Experimental Procedures rating the SH2 and inositol 5-phosphatase domains and an ApaI
site and was inserted into a modified FcgRIIB expression vector, in
Cells, Expression Constructs, and Antibodies which a BstEII site was created by PCR at the sequences corre-
Murine B cell lines were maintained in RPMI 1640 medium supple- sponding to amino-terminal residue of inhibitory motif in FcgRIIB.
mented with 10% FCS (Sigma, Saint Louis, MO), 50 mM 2-mercapto- Mutations for inactivation of the inositol 5-phosphatase catalytic
domain were introduced into three residues in the essential domainethanol, 2 mM L-glutamine, and antibiotics. Chicken B cell lines
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for this activity (Jefferson and Majerus, 1995) by using PCR with
mismatched primers as follows: 5-Pase forward primer, 59-TTCACC
CACCTCTTCTGGCTTG-39 and 5-Pase reverse primer, 59-CATGATG
TCACTGGTACTGCCA-39. Twenty-five micrograms of expression
constructs were transfected by electroporation at 250 V and 960
mF into the FcgRIIB-deficient murine cell line, IIA1.6, or into the
chicken DT40 B cell line together with 2.5 mg of a vector expressing
the puromycin resistance gene. Conditions of drug selection were
1 mg/ml G418 (GIBCO-BRL, Grand Island, NY) for murine B cell lines
and 0.5 mg/ml puromycin (Sigma, Saint Louis, MO) for chicken B
cell lines. Expression level on transfected cell lines was determined
by FACS Calibur (Becton Dickinson, San Jose, CA) with FITC-conju-
gated 2.4G2 staining.
Generation of SHP-1- and SHIP-Deficient DT40 Cells
SHP-1-deficient and SHIP-deficient cell lines were created by ho-
mologous recombination of targeting genomic constructs using
DT40 chicken B cell line, in which targeted integrations take place
in increased frequency (Buerstedde and Takeda, 1991). Evidences
for deletion in each of the cell lines were demonstrated by Southern
blot, Northern blot, and Western blot analyses (data not shown). No
apparent phenotypic alterations were seen in the cells, their growth
capacity, or level of expression of BCR.
Calcium Measurements and Basis
of Receptor Coligation
Cells (5 3 105) were loaded with 2 mM Fura-2/AM (Molecular Probe,
Eugene, OR) in media at 358C for 30 min. After washing cells twice,
cytosolic calcium concentration of z105 cells in 1.5 ml of PBS sup-
plemented with 1 mM CaCl2 and 1 mM MgCl2 was recorded at 510
nm emission wavelength excited by 340 nm and 360 nm using a
Figure 5. Proliferation of DT40 Lines in Response to BCR or BCR- spectrophotometer (model LS50B; Perkin Elmer, Norwalk, CT). Cali-
Inhibitory Receptor Coligation bration and calculation of calcium concentration was performed as
described (Grynkiewicz et al., 1985). The basis for coligation of BCRCells were stimulated with 0, 1, 3, and 9 mg/ml of anti-chicken
IgM followed by intact anti-mouse IgM plus 2.4G2 antibody, which and receptor transfected, which carries FcgRIIB sequence in its
extracellular moiety, is founded on the capacity of Fc portion ofblocks Fc binding to FcgRIIB, resulting in BCR stimulation (broken
line), or intact anti-mouse IgM alone, resulting in coligation of BCR rabbit intact IgG to bind FcgRIIB in low affinity manner (Phillips et
al., 1984). While Fc-containing molecules are fixed on B-cell surfaceto inhibitory receptor (solid line). Cells were stimulated for 18 hr
and labeled with [3H]thymidine during the last 6 hr incubation. (A) by their BCR specificity, FcgRIIB are efficiently cross-linked by the
Fc portions presented as multivalent ligands. Murine B cells were[3H]thymidine incorporation using wild type (WT), SHP-12/2, and
SHIP2/2 DT40 cells transfected with FcgRIIB or FcgRII-KIR. (B) stimulated by adding intact (20 mg) or F(ab9)2 fragment (10 mg) of
rabbit anti-mouse IgG (H 1 L), resulting in coligation of BCR to[3H]thymidine incorporation in DT40 transfected with a mutant
FcgRIIB (Y . F) that is unable to recruit SHIP. Standard errors of receptor transfected or cross-linking BCR alone, respectively. Stim-
ulation of chicken B cells was carried out by adding intact (5 mg)triplicate samples are indicated.
or F(ab9)2 fragment (2.5 mg) of rabbit anti-mouse IgM followed by 1.7
mg of anti-chicken IgM (mouse IgM isotype), resulting in coligation of
Figure 6. DNA Fragmentation in DT40 Lines
Elicited by BCR Stimulation with or without
Inhibitory Receptor Coligation
Cells were stimulated for 12 hr by 1 mg/ml
anti-chicken IgM followed by anti-mouse IgM
plus 2.4G2 or intact anti-mouse IgM alone,
as described in Figure 5. Cells of hypoploidy
(, 2N) were counted as apoptotic cells
(shown with bar), and the percent of apo-
ptotic cells is indicated.
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Figure 7. Model for the Selective Modulation
of Apoptosis by Recruitment of SHIP or
SHP-1
See text for details. PTKs, protein tyrosine
kinases; PLC, phospholipase C; InsP3, inosi-
tol (1,4,5)-triphosphates.
BCR to receptor transfected or cross-linking BCR alone, respec- 2 mg/ml pepstatin. Supernatant of cell lysates was incubated with
2.4G2 antibody-conjugated sepharose at 48C for 15 min. Immuno-tively. Calcium release from intracellular calcium store was mea-
precipitates on sepharose were washed three times in lysis buffersured in 120 mM KCl containing 1 mM EGTA and 20 mM HEPES at
and resuspended in SDS sample buffer. Denatured samples in re-pH 7.2. Cumulative calcium mobilization was evaluated by integra-
duced condition were separated on10% SDS-PAGE andtransferredtion for 4 min of calcium mobilization over the base line given before
to PVDF membrane (Millipore, Bedford, MA). Immunoblots werestimulation as described by the manufacturer.
performed using a single membrane sequentially stained with anti-
SHIP, anti-SHP-1, anti-phosphotyrosine, and FcgRIIBcyt followedNF-AT Activity Measurements
by peroxidase-conjugated secondary antibodies and were detectedCells (107) in 0.5 ml of medium were electroporated at 350 V and
by enhanced chemiluminescence (Amersham, Arlington Heights, IL).500 mF in the presence of 25 mg of luciferase gene construct driven
by NF-AT. Subsequently, aliquots of cell suspension (2 3 105) were
Apoptosis Assaysincubated in 100 ml of medium for 4.5 hr with intact (2 mg) or F(ab9)2 Cells (104) in 100 ml of medium were stimulated with various amountsfragment (1 mg) of rabbit anti-mouse IgG (H 1 L) for murine B cells
of anti-chicken IgM plus rabbit intact anti-mouse IgM (1.5 mg) forstimulation, and intact (0.5 mg) or F(ab9)2 fragment (0.25 mg) of rabbit coligation of BCR to receptor transfected, or plus rabbit intact anti-anti-mouse IgM followed by 0.34 mg of anti-chicken IgM for chicken
mouse IgM (1.5 mg) and 2.4G2 (0.5 mg) for cross-linking BCR alone.
B cell stimulation. Cells were washed once with PBS, and luciferase For growth arrest assay, cells were labeled for the last 6 hr of
activity in the cell lysate was measured with luciferase assay system incubation with 0.5 mCi [methyl-3H]thymidine (74 GBq/mmol, Amer-
(Promega, Madison,WI). NF-ATactivity in the cell lysate was normal- sham, Cleveland, OH) per well and harvested at 18 hr after stimula-
ized to 100% of that from BCR-stimulation protocol. tion. [3H]thymidine incorporation was measured by liquid scin-
tillation (Wallac, Gaithersburg, MD). Assay for nuclear DNA
Immunoprecipitation and Western Blot Analysis fragmentation was described in detail previously (Nicoletti et al.,
Murine B cells (2 3 107) in 1 ml of medium were incubated for 2 min 1991). Cells after 12 hr stimulation (1 mg/ml, anti-chicken IgM) were
at 378C with intact (50 mg), F(ab9)2 fragment (25 mg) of rabbit anti- stained with hypotonic lysis buffer (0.1% sodium citrate, 0.1% Triton
mouse IgG (H 1 L), or PBS alone. Cells were solubilized in lysis X-100) containing 20 mg/ml propidium iodide for 2 hr at room temper-
buffer (1% NP-40, 50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 2 mM ature and subjected to analysis by FACS caliber. Nucleus containing
EDTA, 50 mM NaF, 10% glycerol) supplemented with 2 mM sodium less DNA staining than that in normal diploid nucleus was gated in
as an apoptotic cell.vanadate, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and
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